Sales, Funding & Banking News

Private Equity Firm Offering $250 Million in Cash Advances to Marijuana Businesses

By Anne Holland [Updated 5/2/13] Another crack has appeared in the wall of financial services firms refusing to do business with the cannabis industry. A financial firm based in Delaware has launched a fund of $250 million to offer so-called purchase future receivables (i.e., cash advances to be repaid from ongoing business revenue) and lines […]

Read More

83% of Existing Medical Marijuana Businesses Were Funded by Founders’ Own Wallets

By Anne Holland   As new-to-dispensaries states such as Massachusetts and Connecticut propose requiring dispensary founders to fund huge escrow accounts ($500k for MA and $2 million for CT), in addition to costly licensing fees, the financial face of the industry may begin to change profoundly.  As you can see from the Marijuana Business Factbook’s exclusive […]

Read More

AZ’s MMJ Dispensary Revenues Projected to Reach $440 Million by 2016

By Anne Holland According to an economic impact study of the nascent AZ MMJ dispensary industry, retail sales of medical cannabis in the state could grow to as much as $440 million by 2016, when the industry is expected to reach maturity with 112 regulated dispensaries open. MMJ Business Daily’s own forecasts are about half that […]

Read More

Cannabinoid Research Firm Cannabis Science, Inc. Could Go Under

By Anne Holland  [Updated as of 4/25/12]  According to its annual 2012 report filed today, Cannabis Science, Inc. (PINK:CBIS), may be in danger of shutting its doors. The company’s Form 10-K stated, “At this time, our ability to generate any significant revenues continues to be uncertain. There is substantial doubt about our ability to continue […]

Read More

Cannabis Stocks Start First Quarter With a Bang, End With a Fizzle as Hype Subsides

Most publicly traded cannabis companies got off to an impressive start in 2013, posting steady gains in January and then soaring to 52-week highs in February when hype over the industry’s future reached a fever pitch. But the euphoria has faded, and the majority of marijuana-related stocks closed out the first quarter – which wrapped […]

Read More